Neutral
Redmile Group (NASDAQ: ADCT) reports 9.9% stake after SPV reorg
Redmile Group, LLC has disclosed a 9.9% beneficial ownership stake in ADC Therapeutics (NASDAQ: ADCT) following an internal reorganization. This reorg...